Using monoclonal antibodies, we have examined the expression pattern of MASH1, a basic helix-loop-helix protein that is a mammalian homolog of the Drosophila achaete-scute proteins. In Drosophila, achaete-scute genes are required for the determination of a subset of neurons. In the rat embryo, MASH1 expression is confined to subpopulations of neural precursor cells. The induction of MASH1 precedes, but is extinguished upon, overt neuronal differentiation. MASH1 is expressed in the forebrain by spatially restricted domains of neuroepithelium and in the peripheral nervous system exclusively by precursors of sympathetic and enteric neurons. The features of early and transient expression, in spatially restricted subpopulations of neural precursors, are similar to those observed for achaete-scute. Thus, the amino acid sequence conservation between MASHI and achaete-scute is reflected in a parallel conservation of cell type specificity of expression, similar to the case of mammalian MyoD and Drosophila nautilus. These data support the idea that helix-loop-helix proteins may represent an evolutionarily conserved family of cell-type determination genes, of which MASH1 is the first neural-specific member identified in vertebrates.
sory organs will develop (Ghysen and Dambly-Chaudiere 1989) . However, the precise role of these genes in the process of neuroblast determination is still not clear.
New insights into the function and regulation of AS-C genes have emerged from the determination of their nucleotide sequences (Campuzano et al. 1985; Villares and Cabrera 1987; Gonzalez et al. 1989 ) and from biochemical studies of structurally related genes in mammalian systems (Murre et al. 1989b; Davis et al. 1990 ). The achaete-scute proteins are members of a family of transcription factors with common dimerization and DNA-binding motifs, called the basic helix-loop-helix (bHLH) family (Murre et al. 1989a, b) . Another bHLH protein, called MyoD, is involved in myogenic determination in vertebrates (Davis et al. 1987) , suggesting that the bHLH motif may define a family of cell-type determination genes (Weintraub et al. 1991) . In vitro studies of MyoD and achaete-scute have revealed that they heterodimerize with other, ubiquitously expressed bHLH proteins called E12/E47 (Murre et al. 1989b) , originally identified as a transcription factor for immunoglobulin genes (Murre et al. 1989a) . As E12 appears to be a mammalian homolog of da, the previously observed genetic interac-tions between the achaete-scute and da genes (DamblyChaudiere et al. 1988 ) most likely reflect direct interactions between their protein products.
Recently we isolated cDNAs encoding two mammalian homologs of achaete-scute, called MASH1 and MASH2 (Johnson et al. 1990) , from MAH cells ), a cell line derived from the sympathoadrenal sublineage of the neural crest. The sequences of MASH1 and MASH2 in the bHLH region are more similar to those of achaete-scute than to those of other mammalian bHLH proteins. A similar observation has been made for mammalian and Drosophila MyoD (Michelson et al. 1990 ). Preliminary studies of MASH1 and MASH2 mRNA expression by Northern blotting in different cell lines and tissues suggested that MASH1, at least, is expressed in the developing nervous system (Johnson et al. 1990 ). However, these initial experiments did not examine MASH1 expression at the cellular level or reveal the precise time, lineage specificity, and spatial pattern of MASH1 expression, nor did they examine the expression of the MASH1 protein.
To address these questions, we have raised specific monoclonal antibodies to MASH1 and used them to localize the MASH1 protein in developing rat embryos. We find that MASH1 expression is specific to the nervous system, but precedes overt neuronal differentiation by 12-24 hr. Moreover, in the brain MASH1 is expressed by subsets of neuroepithelial cells, and in the PNS exclusively by precursors in the sympathoadrenal/enteric sublineage. MASH1 expression is transient; the protein disappears concomitantly with the expression of neuronspecific differentiation markers such as neurofilament or SCG10. These features of transient and spatially restricted expression are similar to those exhibited by achaete-scute mRNAs ) and protein (P. Cubas, J.-F. Celis, S. Campuzano, and J. Modolell, in prep.) in Drosophila. This similarity, taken together with the sequence homology between MASH1 and achaete-scute, supports the idea that MASH 1 plays a role in neural determination in vertebrates.
Results

Isolation and characterization of monoclonal antibodies to MASH1
To obtain specific antibodies to MASH1, we overexpressed the protein in Esherichia coli and immunized mice with gel-purified material (see Materials and methods) . From >800 hybridomas screened, we obtained -40 producing antibodies that reacted specifically with the bacterially expressed protein. Of these, two antibodies, called anti-MASH1A and -MASH1B, reacted with the endogenous MASH1 protein in fixed embryo sections (most of the other antibodies failed to do so). These antibodies also stained the nuclei of PC12 and MAH cells, two cell lines known to express MASH1 mRNA (Johnson et al. 1990 ), but did not stain RAT1 fibroblasts, which do not express MASH1 mRNA (data not shown).
The data presented here were obtained with anti-MASH1A, although anti-MASH1B yielded similar results in selected samples (not shown).
The specificity of the anti-MASH1 monoclonal antibodies was characterized in two ways. In the first method, MASH1, MASH2, and a rat El2 protein (S. Birren and D.J. Anderson, unpubl.) were synthesized in a reticulocyte lysate from synthetic mRNA transcribed from their cognate cDNA clones (Fig. 1A, lanes 1-3) . Immunoprecipitation with anti-MASH1A revealed reactivity of the antibody toward MASH1 but not toward MASH2 or El2 (Fig. 1A, lanes 4-6) . No bands were immunoprecipitated with a control antibody of the same subclass (Fig. 1A, lanes 7-9) . Thus, the antibody recognizes MASH1 as distinct from MASH2 or El2. As MASH1 and MASH2 are >90% identical in their sequence in the bHLH region, this experiment suggests that the epitope detected by anti-MASH1A lies outside this region. This makes it highly unlikely that the anti-MASH1A antibody is cross-reactive with other bHLH proteins, which are related primarily in this core region. Similar results were obtained with anti-MASH1B (not shown).
Antibody characterization was also performed by Western blotting. Anti-MASH1A detected a closely spaced 34-kD doublet in MAH cells, the sympathoadrenal progenitor cell line used to isolate the MASH1 cDNA [Fig. 1B, lanes 9, 10 (arrow) ]. This doublet may reflect translational initiation at either of two methionines spaced 7 amino acid residues apart (Johnson et al. 1990) or a post-translational modification. No polypeptides other than MASH1 were detected in MAH cells by the antibody (lane 10; cf. also lanes 4 and 9). No specific band was detected in RAT1 fibroblasts, a control cell line that does not express MASH1 mRNA ( Fig. 1B; cf. lanes 8 and 3). The 34-kD doublet was also detected in embryonic day (E) 12.5 and E13.5 brain (Fig. 1B, lanes 6,7) , but not liver (cf. lanes 1 and 5), consistent with the specificity of MASH1 mRNA expression in these embryonic tissues (Johnson et al. 1990) . Taken together, these data suggest that the anti-MASH1A antibody is highly specific for MASH1 and cross-reacts neither with related bHLH proteins nor with other proteins in cell lines and in embryos.
Expression of MASH1 in the developing CNS
Rat embryos staged from E7.5 to E13.5 were serially sectioned and stained with monoclonal anti-MASH1. Staining was visualized by using either fluorescently labeled or horseradish peroxidase-conjugated secondary antibody. No specific labeling was detected at any stage prior to El0.5, by which time primary neural induction and neurulation have occurred. MASH1 expression was first detected in the CNS at El0.5, a stage preceding the expression of differentiation markers such as neurofilament (Fig. 2) . In the brain, clusters of MASHl-labeled nuclei could be seen in the roof of the presumptive mesencephalon ( Fig. 2A, arrow ) and the diencephalon ( 9) 2B, arrow). Small clusters of faintly stained nuclei were also observed in the ventral telencephalon ( Fig. 2A ; data not shown.) In the developing neural tube, a small number of strongly labeled nuclei were visible flanking the floor plate (Fig. 2C ,D, arrows.) MASH1 expression flanking the floor plate extends rostrally as far as the posterior hindbrain (Fig. 2B , arrowhead) but is not detected in the most caudal regions of the neural tube ( Fig. 2A) . Occasionally, stained nuclei are observed within the floor plate itself (not shown). By Ell.5, labeled nuclei adjacent to the floor plate have become more numerous (Fig. 3A, C, arrows) . At this stage, MASH1 labeling is also detected in the dorsal, but not the intermediate, region of the neural tube (Fig. 3C , arrowheads). When developing motor neurons are visualized by counterstaining sections with antibodies to SCG10, a neuron-specific differentiation marker (Stein et al. 1988) , it is apparent that MASHl-positive nuclei occupy a discrete, intermediate region between the floor plate and the SCG10-positive motor neurons ( Fig. 3 ; cf. A with B and C with D), a region designated as X by Yamada et al. (1991) . At this stage of development, SCG10
is not yet detectable in the dorsal neural tube (Fig. 3D ), indicating that MASH1 expression precedes that of this marker. The segregation of MASH 1-positive nuclei to the dorsal and ventral regions of the neural tube suggests that MASH1 expression is positionally restricted with respect to the dorsoventral axis of the developing spinal cord. However, the spread of MASH1 expression within the dorsal region varies with anterior-posterior position and with stage of development.
By E13.5, the spinal cord contains a well-defined ventricular zone (Fig. 4B , vz) containing mitotic neuroepithelial precursors. Following their terminal mitosis in the ventricular zone, neuroblasts migrate laterally to the marginal zone (Fig. 4B , m z ) w h e r e they differentiate. Thus, newly differentiated neurons and their precursors can be visualized simultaneously in spinal cord sections at this stage of development. MASHl-positive nuclei are restricted to the ventricular zone, in the dorsal aspect of the spinal cord (Fig. 4A, arrow) . In contrast, cells in the marginal zone expressing terminal differentiation markers such as SCG10 (Fig. 4B ) and neurofilament ( Fig. 4C ) are MASH1 negative (Fig. 4A, arrowhead) . These observations suggest that MASH1 expression not only precedes the expression of terminal differentiation markers (Fig. 5B , arrows), but this staining only partially overlaps the distribution of MASH l-positive nuclei. By E12.5, the band of MASH1 expression in the diencephalon has become more pronounced (Fig. 5C , di). The anterior boundary of this band appears to correlate with the boundary between the diencephalon and telencephalon (located ventral to the section illustrated), but the posterior boundary of the band does not correlate with any structure.
Studies in other systems have suggested that posttranscriptional mechanisms may regulate the expression of some bHLH genes (for review, see Weintraub et al. 1991) . We were therefore interested in comparing the pattern of MASH1 mRNA and protein expression. The time of onset of MASH1 protein expression in the brain is similar to that observed for MASH1 mRNA (Johnson et al. 1990) . The same appears true of the spatial distribution of MASH1 expression. In frontal sections of E13.5 midbrain, the MASHl-positive band in the diencephalon can be seen to extend dorsally to the boundary with the mesencephalon (Fig. 6A , arrowhead). In situ hybridization of similar sections with a MASHl-specific cRNA probe ( Fig. 6B ) suggests that the distribution of MASH1 mRNA corresponds to that of the MASH1 protein. A similar correspondence between MASH1 protein and mRNA expression was also seen in sections of E13.5 spinal cord (data not shown). Thus, the available data fail to suggest evidence of post-transcriptional regulation for MASH1. In this respect the regulation of MASH1 appears similar to that of achaete and scute in the Drosophila wing imaginal disc (P. Cubas et al. 1991 ).
MASHl-positive nuclei also occupy a spatially re- stricted region in the presumptive cortex. In the E12.5 telencephalon, staining is confined to the basal region (Fig. 7D , long arrow.) The posterior boundary of MASH1 expression in the basal telencephalon respects the boundary with the diencephalon (Fig. 7D, arrowhead) ; however, the anterior boundary of staining is less sharply defined and has no morphologic correlate. The spatial restriction of MASH1 expression in the telencephalon is seen more dramatically in serial reconstruction of parasaggital sections [ Fig. 7A (tel); C (arrow)]. This reconstruction also revealed widespread but patchy staining in the superior colliculus, metencephalon, and myelencephalon (Fig. 7B, arrows) . The restricted expression of MASH 1 in the forebrain does not result from temporal gradients of development, as expression did not extend into the dorsal region of the telencephalon at later stages. Rather, MASH1 expression in the forebrain becomes even more restricted with subsequent development, becoming localized to the presumptive basal ganglia and optic chiasm at E13.5 (not shown). Staining of selected sections of adult brain and olfactory epithelium with anti-MASH1A has thus far failed to reveal any detectable immunoreactivity (L. Lo, unpubl.).
Expression of MASH1 in the developing PNS
In the rat, neural crest migration occurs between E10.5-Ell.5 in the trunk. MASH1 expression was not detectable in migrating neural crest cells lateral to the neural tube (Fig. 2C,D and data not shown.) However, by E11-11.5, a population of MASHl-positive nuclei could be observed adjacent to the dorsal aorta, in the sympathetic ganglion anlage (Fig. 8A, arrowheads) . Pronounced clustering of these nuclei could be seen in tangential sections (Fig. 8B, arrows) . In frontal (longitudinal) sections, the MASH 1-positive cells appeared as a regularly spaced chain of clumps bordering the aorta ( Stemple, unpubl.). However, for technical reasons double-labeling with the two antibodies could not be performed. Nevertheless, the position of the MASHl-positive nuclei and their likely coexpression of LNGFR strongly suggest that they are neural crest derived. Scattered MASH 1-positive cells were also detected ventral to the sympathetic ganglia in the developing gut where enteric neurons are later generated [ Fig. 9A (g and small arrows)]. MASH1 staining was not detected at any stage examined in dorsal root ganglia (containing sensory neurons), in the Schwann cells associated with ventral roots, or in the subectodermal region where melanocyte precursors would be found. The relationship of MASH 1 expression to that of other markers expressed by sympathetic neuronal precursors was examined by performing double-labeling experiments. At Ell.5, a few weakly SCG10-positive cells could be detected in the area containing MASHl-positive nuclei (Fig. 9C, D, arrows. ) It was not possible to determine at this level of resolution whether individual cells coexpressed both markers, although they are clearly present in the same region. A marker specific for sympathetic neurons is tyrosine hydroxylase (TH), the ratelimiting enzyme in catecholamine biosynthesis. Doublelabeling experiments showed no detectable TH immunoreactivity in the MASHl-positive cell clusters at E11-11.5 (not shown.) At E12.5, however, TH was strongly expressed in sympathetic ganglia, in regions overlapping the MASHl-positive nuclei (Fig. 10A, B, short arrows) . However, the regions of strongest MASH1 staining appeared to correspond to TH-negative regions (cf. long arrows in Fig. 10A, B) . The relative levels of TH and MASH1 staining in E12.5 sympathetic ganglia differed according to axial position within a given embryo, following the rostrocaudal gradient of neural development: In younger caudal ganglia, loose aggregates of strongly MASHl-positive nuclei could be seen, but few TH-positive cells were visible (Fig. 10C, D , uppermost long arrows); in contrast, in more anterior ganglia, only faint MASH1 staining could be seen in the TH-positive ganglia (Fig. 10C, D, lower long arrows) . By E13.5, MASH1 staining has essentially disappeared from the ganglia, although occasional positive cells can be seen (data not shown). The reciprocal patterns of MASH1 and TH expression in developing sympathetic ganglia strongly suggest that as in the CNS, precursor cells extinguish MASH1 expression as they activate expression of differentiation markers.
D i s c u s s i o n
The expression pattern of MASH1 is analogous to that of Drosophila achaete-scute Emerging evidence suggests that bHLH proteins are involved in the process of cell-type determination (Weintraub et al. 1991) . In Drosophila, bHLH proteins encoded by the achaete-scute complex are required for the determination of subsets of neurons (for review, see Ghysen and Dambly-Chaudiere 1988) . We have used a monoclonal antibody to examine the expression pattern of MASH1, a mammalian protein that shares 88% amino acid sequence identity with achaete-scute in its bHLH region (Johnson et al. 1990 ). Our results point to several analogies in the main features of MASH1 and achaetescute expression. First, MASH1 is expressed specifically c :iL!:~ ~ ¸¸¸¸~¸~II z! in both the developing CNS and PNS, and the achaetescute genes are required for the development of neurons in both the CNS and PNS. Second, MASH1 expression appears to be localized to subsets of neuroepithelial cells.
In the Drosophila PNS, the achaete-scute complex is required for the determination of a subset of sensory mother cells that give rise to external sensory (es) organs (Ghysen and O'Kane 1989} . Third, expression of MASH1 precedes overt neuronal differentiation, as determined by the expression of neuron-specific markers such as SCG 10 and neurofilament. In the Drosophila wing imaginal disc, the achaete protein appears in sensory mother cells two divisions prior to the differentiation of sensory neurons P. Cubas et al. 1991) . Fourth, MASH 1 expression is transient, becoming extinguished at or before overt differentiation. Similarly, in the wing imaginal disc, expression of the achaete protein is extinguished as the sensory mother cells initiate their terminal cell divisions ( P. Cubas et al. 1991 ) . These similarities in MASH1 and achaete-scute expression, taken together with their conservation of amino acid sequence, support the notion that MASH1 is a vertebrate neuronal determination gene.
Evolutionary conservation of cell type determination
The observation that MASH1 is expressed specifically in early neuroepithelial precursor cells, like achaete-scute, parallels the observations that the Drosophila and Caenorhabditis elegans homologs of MyoD are expressed specifically in myogenic precursors, like their vertebrate counterparts (Krause et al. 1990; Michelson et al. 1990 ). Taken together, these data suggest that there has been a parallel evolutionary conservation of amino acid sequence and cell type specificity for at least some bHLH genes. Such conservation is consistent with the idea (Weintraub et al. 1991 ) that these genes comprise a family of cell-type determination factors. However, there are differences between the expression patterns of myogenic and neurogenic bHLH genes in their respective lineages.
Both MASH1 and achaete-scute expression are extinguished at or before overt differentiation. In contrast, the myogenic bHLH genes are expressed not only before but also after the onset of myogenesis (Sassoon et al. 1989 ). Because myogenic bHLH proteins are able to activate the transcription of muscle-specific structural genes , it is thought that they are not only involved in determination but also in differentiation. In contrast, it seems unlikely that MASH1 is directly involved in maintaining the differentiated state. MyoD and MASH1 may therefore act in their respective lineages at stages that are overlapping but distinct. Evidence from Drosophila suggests that there are other neural-specific bHLH genes expressed later in development than achaete-scute (Jan and Jan 1990) ; perhaps the development of neurogenic lineages occurs through a cascade of related genes. 
Control of MASH1 expression
The pattern of MASH1 expression raises the question of what factor(s) regulate the expression of this presumptive regulatory protein. In the developing spinal cord, MASHl-positive nuclei are found adjacent to the floor plate. A recent series of experiments has revealed that the floor plate possesses an inductive activity that is able to pattern the development of the ventral spinal cord (Yamada et al. 1991) , raising the possibility that the floor plate may activate expression of MASH1 in adjacent cells. One substance that has been implicated as a possible floor plate-derived inducer is retinoic acid (Wagner et al. 1990) . In this respect, it is of interest that MASH1 expression is induced by retinoic acid in P19 cells, an embryonal carcinoma cell line (J.E. Johnson, unpubl.) . However, the observation that MASH1 is also expressed in the dorsal neural tube implies that the floor plate is not the exclusive inducer of MASH1 expression. Rather, MASH1 is likely to be regulated by different factors in different regions of the nervous system.
MASH1 expression as evidence of a prepattern in the developing forebrain
In the developing CNS, MASH1 appears to be expressed in spatially restricted subsets of neuroepithelial cells. In the forebrain, in particular, restricted zones of MASH1-positive nuclei are observed. In some areas, the boundaries of MASH1 expression correlate with morphologic boundaries between structures, such as the diencephalon and telencephalon; in other regions, MASH1 boundaries exist in a seemingly homogeneous neuroepithelium. The restricted domain of MASH1 expression in the basal telencephalon is particularly striking (Fig. 7) . Although the telencephalon has not yet been fate-mapped, the region of MASH1 expression may correspond to the presumptive basal ganglia. Spatially restricted domains of transcription factor expression have been shown to precede overt patterning in the hindbrain (Wilkinson et al. 1989) and to correspond to cell lineage compartments (for review, see Lumsden 1990) . Recent cell-lineage analyses have supported the existence of compartment-like boundaries to cell mixing along the anteroposterior axis of the forebrain (Austin and Cepko 1990; Crandall and Herrup 1990; Fishell et al. 1990 ): To our knowledge, the restricted expression of MASH1 represents the first example of spatially restricted transcription factor expression in the embryonic forebrain. It will be necessary to map the fate of the MASHl-expressing cells before the relationship of the expression pattern to cell lineage boundaries or functional subdivisions in the forebrain can be adequately assessed.
MASH1 may be a determination gene for the sympathoadrenal lineage
The expression of MASH1 in the neural crest-derived sympathoadrenal lineage (Patterson 1990 )provides the one system, so far, in which this gene can be linked to the development of a specific neuronal cell type. MASHl-positive nuclei are found in the location where sympathetic neurons will develop, but 24 hr prior to the expression of sympathoadrenal lineage markers. Subsequently, MASH1 expression fades as TH, a marker of sympathoadrenal progenitors (Anderson and Axel 1986) , appears. The reciprocal intensities of MASH1 and TH expression within individual ganglia at E12.5 strongly suggest that MASH 1-positive cells are developing into TH-positive cells. Expression is not detected in other locations colonized by neural crest cells, with the exception of the gut (see below). The specificity of MASH1 expression in sympathetic ganglia is consistent with the fact that the MASH1 cDNA was initially isolated from MAH cells, an immortalized sympathoadrenal progenitor cell line . In MAH and PC12 cells, however, MASH1 is coexpressed with high levels of TH (Johnson et al. 1990 ), a cell state not observed in vivo. The immortalized nature of these lines may induce a partial reversion to an earlier stage of development that permits MASH1 expression. Whatever the case, the expression of MASH1 in PC12 and MAH cells clearly does not prevent the expression of later differentiation markers such as TH and SCG10.
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In the PNS, MASH1 is also detected in scattered cells within the embryonic gut. One day later in development, cells expressing TH can be observed in the gut, as well (Baetge and Gershon 1989; Baetge et al. 1990 ). The apparent conversion of MASH1-to TH-expressing cells in sympathetic ganglia suggests a similar lineal relationship for such cells in the gut. It is thought that THexpressing cells in the gut are precursors of enteric neurons (Baetge et al. 1990 ) and m a y be similar or identical to sympathoadrenal progenitors (J. Carnahan, D. Anderson, and P. Patterson, in prep.) . Taken together, these facts that MASH1 is expressed one day earlier than term i n a l differentiation markers and is a transcription factor (J.E. Johnson, S.J. Birren, T. Saito, and D.J. Anderson, unpubl.) raise the possibility that it functions in the det e r m i n a t i o n of this neuronal sublineage. However, the transiently M A S H l -p o s i t i v e cells of the s y m p a t h e t i c ganglia could potentially give rise to glia as well as to neurons (as is the case for achaete-scute-expressing precursors in the Drosophila PNS). Because peripheral glia develop in other sites of crest migration where MASH1 is not expressed, the f u n c t i o n of MASH1 could, in this case, be to generate both glia and neurons in a particular place (i.e., the s y m p a t h e t i c ganglia) rather t h a n to specify cell type per se. Reverse-genetic experiments in the m o u s e should provide a m e a n s of resolving this question and of determining the extent to w h i c h the conservation of sequence and lineage specificity between MASH1 and the achaete-scute genes reflects a true conservation of function. 
Materials and m e t h o d s
Recombinant pET-MASH1 production
A MASH1 cDNA was expressed in bacteria under the control of the phage T7 RNA polymerase (Studier et al. 1990 ). An NcoI site was introduced into the first ATG by site-directed mutagenesis using the Amersham kit, and a restriction fragment extending from this site to a BamHI site 60 bp upstream of the stop codon was cloned into the vector pET. Induction of the recombinant protein was accomplished by the addition of 0.4 mM IPTG. Recombinant MASH1 was the major polypeptide species observed on one-dimensional SDS gels of the inclusion body fraction (not shown). The protein was purified further by preparative electrophoresis and was judged to be essentially free of contaminants upon re-electrophoresis.
Immunization procedures
Mice were immunized with electroeluted, acetone-precipitated pET-MASH1 protein emulsified in complete Freund's adjuvant. A boost without adjuvant was administered after 2 weeks. Each mouse received 75 fag of antigen per injection. Three days after the boost, the mouse was sacrificed and its spleen cells fused with HL-1 myeloma cells. Cells (2 x 105/well) were plated in 96-well microtiter dishes containing HL-1 serum-free medium with AAT as the selective agent (Kohler and Milstein 1975) .
Antibody screening and immunocytochemical studies
Initial screening of the hybridoma supernatants was carried out by dot blot. One microgram of antigen was spotted on nitrocellulose paper (BA85, 0.45 ~m; Schleicher & Schuell). The paper was then blocked for I hr at room temperature in 3% gelatin, 10 mg/ml of BSA in Tris-buffered saline (TBS), and incubated with hybridoma supernatant overnight at 4°C, followed by horseradish peroxidase (HRP)-conjugated goat anti-mouse immunoglobulin (Chemicon) at a 1:200 dilution. Color development was performed with 0.5 mg/ml of 4-chloro-l-napthol in 0.01% hydrogen peroxide for 10 rain at room temperature. Positive mother clones were then rescreened immediately by immunohistochemistry on paraformaldehyde-fixed PC12 and RAT1 fibroblast cells and on frozen sections of E13.5 neural tubes (a stage of development when MASH1 was known to be expressed on the basis of earlier Northern blot analysis.) Of 803 wells initially screened, 44 positive mother clones were identified by the dot blot assay. Four of these clones, in turn, exhibited nuclear staining on PC12 but not RAT1 cells and stained sections of E13.5 embryos; the remainder failed to react with the fixed MASH1 protein in vivo.
For immunocytochemistry, rat embryos aged E7.5-E14.5 (Sprague-Dawley, obtained from Simonsen Breeding Laboratories; age designated as E0.5 the morning following a midnight mating) were fixed by immersion in freshly prepared 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.2) for at least 1 hr at room temperature, depending on the age of the embryo. Fixation carried out at 4°C significantly reduced the sensitivity of staining. Staining intensity was also reduced if embryos were stored in PBS on ice for significant lengths of time during the collection of material, suggesting that the antigen is labile in vivo. Following fixation, embryos were equilibrated in 30% sucrose in PBS for cryoprotection prior to embedding and cryostat sectioning. Immunoperoxidase staining was performed on frozen sections that were preblocked in 10% horse serum plus 0.2% Tween 20 in TBS for 30 min at room temperature, followed by incubation with hybridoma supernatant diluted 1 : 1-1 : 4 in TBS with 0.1% Tween 20 (TTBS) overnight at 4°C. After being washed twice in TTBS for 15 min each, sections were developed with an avidin-biotin-HRP system (Vectastain ABC kit, Vector Labs, Burlingame, CA) according to the manufacturer's instructions. Endogenous peroxidase activity was eliminated from the sections by incubating in 0.3% H202 in methanol for 30 min at room temperature following binding of the biotinylated secondary antibody. Color development was performed by using diaminobenzidine (DAB). Alternatively, sections were developed for immunofluorescence following primary antibody treatment by incubating with FITC-goat antimouse IgG (TAGO, Inc.) at 1 : 200.
Rabbit antibodies to SCG10 were used at 1 : 250 dilution and visualized by using rhodamine-goat anti-rabbit (TAGO) antibodies at 1:200 dilution. Antibody to neurofilament (clone BF10, Boehringer Mannheim Biochemicals) was used at a 1 : 40 dilution and visualized by using biotinylated goat anti-mouse IgG and the Vectastain ABC kit.
Data for serial reconstruction of sections were acquired with a motorized microscope stage (Stahl Research) and a digitizer, and stored on an IBM PC-XT. The data were transferred to an Iris 2400 computer (Silicon Graphics, Mountain View, CA), and reconstruction was performed with customized analysis software (J. Knierim and D. Bilitch, unpubl.) . 
In situ hybridization
In situ hybridization was performed essentially as described previously (Anderson and Axel 1985) , The probe used consisted of a 175-bp BamHI fragment containing 60 residues of carboxyterminal-coding sequence and 115 residues of 3'-untranslated sequence. This probe lies 3' of the bHLH region and does not cross-hybridize with MASH2 or any other related sequences. Antisense riboprobes for in situ hybridization were generated by transcription of BamHI-linearized templates with T7 RNA polymerase.
In vitro transcription and translation
In vitro transcription and translation of cDNA clones were performed as described (Davis et al. 1990 ) with a rabbit reticulocyte lysate kit and other reagents from Promega. The MASH1 and MASH2 cDNAs containing the complete coding regions were described previously (Johnson et al. 1990 ). The rat El2 cDNA clone was isolated from a MAH cell cDNA library (S. Birren, unpubl.) and will be described separately (J.E. Johnson, S.J. Birren, T. Saito, and D.J. Anderson, in prep.) .
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